Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,124.00
Bid: 1,122.00
Ask: 1,128.00
Change: -2.00 (-0.18%)
Spread: 6.00 (0.535%)
Open: 1,122.00
High: 1,124.00
Low: 1,114.00
Prev. Close: 1,126.00
VCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM and Q1 Interim Management Statement

4 Feb 2015 07:00

RNS Number : 9655D
Victrex PLC
04 February 2015
 



 

 

 

 

 

 

4 February 2015

Victrex plc

AGM and Q1 Interim Management Statement

'A solid start to 2015'

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its first quarter (Q1) Interim Management Statement ahead of its Annual General Meeting being held this morning.

Overall, Victrex has seen a solid start to 2015. Group revenue of £59.8m was 14% ahead of the prior year (Q1 2014: £52.4m), with Group sales volume of 967 tonnes 42% ahead of the prior year (Q1 2014: 679 tonnes). The strong volume comparative in Q1 largely reflects current Consumer Electronics business that did not contribute to the prior year quarter. Excluding Consumer Electronics, volume growth in the underlying business was slightly ahead year on year.

In our VPS business, Q1 continued to benefit from Consumer Electronics - in line with our previous guidance - and we now expect the current Consumer Electronics opportunity to continue into the second half of our financial year.

In our Invibio medical business, revenue was weaker in Q1.This reflects some short term impact from the current consolidation in the US medical device industry and we anticipate that Invibio will still make progress over the full year. Our focus for 2015 remains the roll-out of new products into the Spine market, alongside pre-development work for our new product platforms of Dental, Trauma and Knee.

David Hummel, Chief Executive of Victrex, said: "Overall, Victrex has made a solid start to 2015 and our focused strategy is helping to continue our growth momentum. At this early stage of the year, our expectations are unchanged and we remain well placed for the year ahead."

Victrex remains in a strong financial position, with a healthy balance sheet, good cash generation and no significant changes to our financial position since 30 September 2014.

Enquiries:

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 7809 595831

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

David Hummel, Chief Executive +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead / Rebecca Hall +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Every day, millions of people rely on products or applications which contain our materials, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Find out more at www.victrexplc.com

 

Analyst and investor call:

A conference call for analysts and investors will be held this morning at 09.00am. Please contact Laura Stewart at Pendomer Communications for details on +44 (0) 203 603 5220 or laura.stewart@pendomer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSTJMPTMBTMBTA
Date   Source Headline
19th May 201411:57 amRNSDirector/PDMR Shareholding
30th Apr 20143:16 pmRNSTotal Voting Rights
17th Apr 20142:01 pmRNSDirector/PDMR Shareholding
10th Apr 20142:49 pmRNSHolding(s) in Company
8th Apr 20147:00 amRNSTrading Statement
3rd Apr 20141:33 pmRNSHolding(s) in Company
31st Mar 20144:25 pmRNSTotal Voting Rights
18th Mar 20144:29 pmRNSDirector/PDMR Shareholding
12th Mar 20143:08 pmRNSHolding(s) in Company
3rd Mar 201410:18 amRNSHolding(s) in Company
28th Feb 20142:00 pmRNSTotal Voting Rights
19th Feb 20145:04 pmRNSDirector/PDMR Shareholding
18th Feb 201412:01 pmRNSDirector/PDMR Shareholding
4th Feb 20142:17 pmRNSResult of AGM
4th Feb 20147:00 amRNSAGM and Q1 Interim Management Statement
31st Jan 20143:30 pmRNSDirectorate Change
31st Jan 20149:00 amRNSTotal Voting Rights
17th Jan 201410:07 amRNSDirector/PDMR Shareholding
15th Jan 20144:42 pmRNSHolding(s) in Company
14th Jan 20143:06 pmRNSDirector/PDMR Shareholding
2nd Jan 201411:37 amRNSAnnual Financial Report
31st Dec 20137:00 amRNSTotal Voting Rights
17th Dec 20135:17 pmRNSDirector/PDMR Shareholding
17th Dec 20134:47 pmRNSDirector/PDMR Shareholding
17th Dec 201311:36 amRNSDirector/PDMR Shareholding
13th Dec 20133:14 pmRNSHolding(s) in Company
10th Dec 20137:00 amRNSFinal Results
2nd Dec 20134:19 pmRNSBlocklisting Interim Review
29th Nov 20138:39 amRNSTotal Voting Rights
19th Nov 20132:16 pmRNSDirector/PDMR Shareholding
13th Nov 20133:33 pmRNSDirector Declaration
7th Nov 20137:00 amRNSDirectorate Change
31st Oct 20132:47 pmRNSTotal Voting Rights
25th Oct 201311:46 amRNSHolding(s) in Company
17th Oct 20132:31 pmRNSDirector/PDMR Shareholding
14th Oct 20133:51 pmRNSHolding(s) in Company
14th Oct 20133:48 pmRNSHolding(s) in Company
10th Oct 20137:00 amRNSInvestor Day
8th Oct 20137:00 amRNSTrading Statement
1st Oct 20134:31 pmRNSHolding(s) in Company
30th Sep 20132:56 pmRNSTotal Voting Rights
17th Sep 20133:35 pmRNSDirector/PDMR Shareholding
11th Sep 20133:45 pmRNSHolding(s) in Company
4th Sep 20138:42 amRNSDirector Declaration
30th Aug 20131:53 pmRNSHolding(s) in Company
30th Aug 20138:33 amRNSTotal Voting Rights
19th Aug 20134:07 pmRNSDirector/PDMR Shareholding
2nd Aug 20138:48 amRNSHolding(s) in Company
29th Jul 20137:56 amRNSDirector Declaration
25th Jul 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.